-
Long-lasting opioid treatment recommended by an EMA committee
europeanpharmaceuticalreview
May 05, 2019
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
-
Heroin vaccine could tackle opioid addiction
europeanpharmaceuticalreview
April 30, 2019
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
-
Medical cannabis significantly safer for elderly with chronic pain than opioids
europeanpharmaceuticalreview
April 30, 2019
Medical cannabis significantly safer for elderly with chronic pain than opioids.
-
CDC Provides Clarification of Opioid Prescribing Guideline
drugs
April 25, 2019
CDC Provides Clarification of Opioid Prescribing Guideline
-
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose
drugs
April 22, 2019
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose
-
Sixty People Charged in Massive Opioid Painkiller Investigation
drugs
April 19, 2019
Sixty People Charged in Massive Opioid Painkiller Investigation.
-
Opioid crisis cost US government nearly $38 billion in lost taxes
pharmafiles
April 12, 2019
The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, according to researchers from Pennsylvania State University.
-
FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid
drugs
April 11, 2019
FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid.
-
Purdue agrees to pay $270 million to Oklahoma to resolve OxyContin lawsuit
firstwordpharma
March 27, 2019
Purdue Pharma agreed on Tuesday to pay about $270 million to Oklahoma to resolve allegations that the drugmaker fuelled the opioid crisis through its aggressive marketing of OxyContin (oxycodone).
-
Opioid Rxs Decreasing, But Not for All Doctors
drugs
March 14, 2019
Doctors may be pulling out their prescription pads less often for opioid medications, but not everyone's on the same page yet.